GlassScriptPhysician profile
Ravy Chan
NPI 1902116296
$5,137.45
in general payments reported to CMS, 2019-2025
18 companies · $3,858 in 2025
The $3,858 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2024: $1,165 · 2025: $3,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,016 · Education: $6.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,015.71 |
| Education | $6.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $836.86 | 2024-2025 | Dupixent, Libtayo |
| Abbvie INC. | $745.06 | 2024-2025 | |
| Incyte Corporation | $686.67 | 2024-2025 | Opzelura, Opzelura |
| Botanix Sb INC | $503.81 | 2025 | Sofdra |
| Ucb, INC. | $420.53 | 2024-2025 | Bimzelx |
| Pfizer INC. | $368.97 | 2024-2025 | |
| Janssen Biotech, INC. | $317.21 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $312.48 | 2024-2025 | |
| Leo Pharma INC. | $218.64 | 2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $205.55 | 2024-2025 | |
| Lilly USA, LLC | $136.15 | 2024 | Olumiant, Taltz |
| Arcutis Biotherapeutics, INC. | $125.09 | 2024-2025 | Zoryve |
| Revance Therapeutics, INC. | $83.92 | 2025 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $81.01 | 2024-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $28.40 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $27.06 | 2024 | Vtama |
| Organon LLC | $23.60 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.44 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravy Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.